AstraZeneca, the SPARK Norway programme at University of Oslo and Oslo Cancer Cluster enter a new mentoring collaboration for life science start-ups.
A new collaboration between the pharmaceutical company AstraZeneca, the SPARK Programme at Norway’s largest life science university and Norway’s only cancer cluster is set in motion to grow the life science sector in the Nordics. At the core of the collaboration is AstraZeneca’s business and science mentoring programme, called AstraZeneca Exchange Nordics.
|10:15–10:20||Welcome and introduction – Jutta Heix, Oslo Cancer Cluster|
|10:20–11:00||AstraZeneca Exchange Nordics: a business and science mentoring program supporting entrepreneurs and start-ups + Q&A – Pernilla Isberg, Director, Operation, AstraZeneca BioVentureHub|
|11:00–11:45||Partnering and collaborating with AstraZeneca + Q&A – Richard Ward, Executive Director, Search and Evaluation, (Oncology R&D Business Development) AstraZeneca|
|From 11:45||Networking lunch|